Global Ophthalmic Market: Focus on Glaucoma

Glaucoma is a type of disease that causes an irreversible blindness, if it is left undetected or untreated. Moreover there is no cure for glaucoma and regular medication is the only way to prevent blindness. In fact this is one of the main issues in the treatment of glaucoma, regularity in taking a proper medication course. Most people are not able to take the complete medication and the rate of medication regimen non-compliance is very high.

Nearly half of the people who are being prescribed for medication discontinue only after six months due to various reasons. Another inherent characteristic of glaucoma and a deterrent in proper treatment is that most of the times this disease goes unnoticed.

The market for ophthalmology and glaucoma consists of prescription or treatment and surgical or detection devices. The prescription or pharmaceuticals market is comparatively larger than the devices market both for ophthalmic and glaucoma. Contact Lenses is another significant market for ophthalmology. Region-wise US is the largest market for ophthalmic and glaucoma alike, and the global market is about 2-3 times that of the US market. Alcon, Allergan, Merck and Pfizer are main players.

The report focuses on glaucoma as a major ophthalmic market. The various aspects of glaucoma are discussed like glaucoma as a disease, types of glaucoma, and treatment of glaucoma. Global as well as US market size and forecasts are given for ophthalmic as well as glaucoma market. The market trends and the latest product developments in this field are also discussed. The major players operating in the market have also been profiled.